Given the emerging evidence that tau-mediated neurodegeneration is caused by a combination of factors, including mitochondrial dysfunction (Thies and Mandelkow, 2007), it is plausible that MAPT variation contributes to the risk of blindness in LHON mtDNA mutation carriers. The gene discussed is MAPT; the disease is blindness (disorder).